PROCEEDINGS VOLUME 5315
BIOMEDICAL OPTICS 2004 | 24-29 JANUARY 2004
Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy XIII
BIOMEDICAL OPTICS 2004
24-29 January 2004
San Jose, CA, United States
Promoting PDT Efficacy
Proc. SPIE 5315, Effects of the bile acid UDCA on PDT efficacy in vitro and in vivo, 0000 (14 June 2004); doi: 10.1117/12.524539
Proc. SPIE 5315, Considerations on the role of cardiolipin in cellular responses to PDT, 0000 (14 June 2004); doi: 10.1117/12.531208
Vascular Effects of PDT
Proc. SPIE 5315, Differential vascular response and relationship to tumor response with photodynamic therapy using WST-09 (TOOKAD), 0000 (14 June 2004); doi: 10.1117/12.527540
Proc. SPIE 5315, Preclinical studies of vascular acting photosensitizer bacteriopheophorbide for the treatment of prostate cancer, 0000 (14 June 2004); doi: 10.1117/12.528379
Synthesis and Monitoring PDT Effects
Proc. SPIE 5315, Singlet oxygen generation and dark toxicity of a nido- and a closo-carboranylporphyrin, 0000 (14 June 2004); doi: 10.1117/12.531903
Proc. SPIE 5315, Role of cell type and animal species in tumor metastasis, 0000 (14 June 2004); doi: 10.1117/12.533550
Proc. SPIE 5315, Synthesis and photodynamic activities of modified benzochlorin derivatives on nasopharyngeal carcinoma cells, 0000 (14 June 2004); doi: 10.1117/12.527557
Bacterial Photodamage and Drug Delivery
Proc. SPIE 5315, Pulsed photodynamic inactivation of gram-negative bacteria: in vitro study using methylene blue, 0000 (14 June 2004); doi: 10.1117/12.530817
Proc. SPIE 5315, Targeted photodynamic therapy of established soft-tissue infections in mice, 0000 (14 June 2004); doi: 10.1117/12.528390
Clinical Applications
Proc. SPIE 5315, Phase I trial of motexafin-lutetium-mediated interstitial photodynamic therapy in patients with locally recurrent prostate cancer, 0000 (14 June 2004); doi: 10.1117/12.529181
Proc. SPIE 5315, Optimization of light dosimetry for photodynamic therapy of Barrett's esophagus, 0000 (14 June 2004); doi: 10.1117/12.528017
PDT Technology
Proc. SPIE 5315, Optical fibers for improved light delivery in photodynamic therapy and diagnosis, 0000 (14 June 2004); doi: 10.1117/12.529489
Proc. SPIE 5315, Light dosimetry at tissue surfaces for oblique incident circular fields, 0000 (14 June 2004); doi: 10.1117/12.529827
Proc. SPIE 5315, Chemiluminescence detection of reactive oxygen species during photodynamic therapy, 0000 (14 June 2004); doi: 10.1117/12.528576
Poster Session
Proc. SPIE 5315, In vivo determination of the absorption and scattering spectra of the human prostate during photodynamic therapy, 0000 (14 June 2004); doi: 10.1117/12.528968
Proc. SPIE 5315, Photodynamic inactivation of somatic frog nerve ex vivo, 0000 (14 June 2004); doi: 10.1117/12.530743
Proc. SPIE 5315, Photodynamic therapy and fluorescent diagnostics of skin cancer with radochlorine and photosense: comparing efficacy and toxicity, 0000 (14 June 2004); doi: 10.1117/12.537787
Proc. SPIE 5315, Photodynamic therapy and fluorescent diagnostics of breast cancer, 0000 (14 June 2004); doi: 10.1117/12.538107
Bacterial Photodamage and Drug Delivery
Proc. SPIE 5315, Photodynamic therapy for the treatment of metastatic lesions in bone: studies in rat and porcine models, 0000 (14 June 2004); doi: 10.1117/12.548174
Back to Top